Product Information
Registration Status: ActiveSIN13922P
MENACTRA, SOLUTION FOR INJECTION is approved to be sold in Singapore with effective from 2011-02-24. It is marketed by SANOFI-AVENTIS SINGAPORE PTE LTD, with the registration number of SIN13922P.
This product contains Diptheria Toxoid Protein 48 microgram (Diptheria toxoid quantity is approximate,Meningococcal (Serogroup A) Polysaccharide (Monovalent Conjugate) dependent on the conjugate polysaccharide to protein ratio),Meningococcal (Serogroup C) Polysaccharide (Monovalent Conjugate) 4 microgram,Meningococcal (Serogroup W-135) Polysaccharide (Monovalent Conjugate) 4 microgram, and Meningococcal (Serogroup Y) Polysaccharide (Monovalent Conjugate) 4 microgram in the form of INJECTION, SOLUTION. It is approved for INTRAMUSCULAR use.
This product is manufactured by Sanofi Pasteur Inc. in UNITED STATES.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.